Newsletter_12-2022_EN

Fachbeiträge, redaktionelle Beiträge und Veranstaltungen In einer sich schnell entwickelnden Branche sind aktuelle Informationen wichtig. reinraum online bietet einerseits Interessierten die Möglichkeit, sich aktuell und umfassend über die Reinraum-Branche zu informieren. Andererseits können Unternehmen und Personen die Plattform nutzen, Fachbeiträge, redaktionelle Artikel und Firmennews zu veröffentlichen. Ein Veranstaltungskalender ergänzt das Informationsangebot. Der ExpertenPool hilft bei der Profi-Suche: WER macht WAS im Reinraum. Fachbeiträge, redaktionelle Beiträge und Veranstaltungen
In einer sich schnell entwickelnden Branche sind aktuelle Informationen wichtig. reinraum online bietet einerseits Interessierten die Möglichkeit, sich aktuell und umfassend über die Reinraum-Branche zu informieren. Andererseits können Unternehmen und Personen die Plattform nutzen, Fachbeiträge, redaktionelle Artikel und Firmennews zu veröffentlichen. Ein Veranstaltungskalender ergänzt das Informationsangebot.
Der ExpertenPool hilft bei der Profi-Suche: WER macht WAS im Reinraum.

05.12.2022 Views

www.reinraum.de NEWSLETTER www.cleanroom-online.com Edition EN 12-2022 | Page 20/42 Cellefill, a new integrated solution to fast-track cell, gene and biological therapies Aseptic fill/finish experts Flexicon Liquid Filling, part of Watson-Marlow Fluid Technology Solutions (WMFTS), and barrier technology specialists Franz Ziel GmbH, today announce the launch of Cellefill- a turnkey, vial fill/finish system with an integrated barrier solution. Enhancing good manufacturing practice (GMP), customer compliance and efficient aseptic manufacturing is essential as new advanced therapy medicinal products (ATMPs), including cell, gene and biological products advance through clinical trials to commercialisation. To meet these new requirements, Cellefill integrates the features of Flexicon’s FPC60 aseptic vial filling machine with barrier technologies from Franz Ziel. Cellefill’s process design includes use of asepticsu single-use-systems (SUS) and pre-sterilised ready to use (RTU) product containers that enter the Grade A filling zone by a No Touch Transfer (NTT) debagging system. Cellefill is a GMP compliant solution that delivers enhanced levels of process flexibility to accelerate production of ATMPs and biological therapies. The emerging role of personalised medicine in ATMPs and biological therapies has led to a shift in how manufacturers approach batch production methods. Biopharmaceutical companies are increasingly looking for ways to manufacture the smaller batches needed for patient-specific medicines, in a way that is cost-effective to produce and validate. Meeting these customer needs, Cellefill maximises production efficiency with features including recipe driven, remote set-up, zero waste start-up and no format parts for the entire vial range. Steve Adams, Product Manager for Cellefill at WMFTS, says: “Through process flexibility, Cellefill enables the scale out and process repeatability our customers need to assure product quality at all levels of manufacturing. Providing expert guidance and support through a single point of contact, we are a committed project partner to biopharmaceutical companies at the cutting-edge of personalised medicine. „The challenge for the industry is to produce these new therapies quickly, safely and cost efficiently, with a system that can be rapidly changed over between batch or different small batch medicines.” Designed to suit various filling requirements and class cleanrooms, the Cellefill solution is available in three models with different barrier technologies. Each model delivers enhanced levels of process and quality assurance with highly accurate peristaltic pump performance, integrated barrier and environmental monitoring. Cellefill builds on the partners’ experience in providing technology and extensive support through validation, qualification and operator training to facilitate a smooth transition into GMP compliant and cost-effective manufacturing. Markus Horsch, division manager sales and marketing from Franz Ziel says: “Cellefill is a fully integrated vial fill/finish and barrier technology solution supporting enhanced levels of product quality and sterility assurance to mitigate risks of contamination. Cellefill adopts pre-designed and configurable modules to reduce project time and fast track therapies to market. „Cellefill minimises batch changeover time with enhanced cleanability, rapid Vapour-phase Hydrogen Peroxide (VHP) cycle times and gloveless operation in the aseptic core, while retaining the possibility of risk-based compliant interventions if needed in rare incidences to prevent batch loss.” The Cellefill solution enables a streamlined project timeline with integrated technical and GMP documentation to increase efficiency of the project validation and qualification stages. The modularity, flexibility, scale out capabilities and efficiencies establish Cellefill as a next generation vial fill/finish solution for new ATMP and biologic products as they advance through clinical trials to commercialisation. Watson-Marlow GmbH D 41569 Rommerskirchen

www.reinraum.de NEWSLETTER www.cleanroom-online.com Edition EN 12-2022 | Page 21/42 Partners against grime Lercher Werkzeugbau: Family business from Austria produces dental technology components Not precise but super-precise; not hygienic but ultra-hygienic. When it comes to products for medical technology, precision and technical excellence are crucial. This is something that Lercher Werkzeugbau GmbH & Kunststoffspritzguss from Klaus in Vorarlberg, Austria, knows only too well. The company is currently moving into medical technology with its own clean room production. And ARBURG is an essential partner here. The company produces plastic dental parts with a machine that is directly connected to a clean room. These are then combined to form an assembly. The hybrid ALLROUNDER 520 H with clean room equipment transports the encapsulated items to another, larger clean room where part inspection and packaging take place. At the end of this clean room, the goods are packed ready for delivery. The products are made of PBT and PE. A total of four machines are planned for the final expansion of the system. “ARBURG has a great deal of experience and knowledge in all areas, and especially in automation and medical technology. We notice this again and again,” says Sandra Ender-Lercher, Managing Director of the family business, praising the cooperation and support in general. Hybrid ALLROUNDER first choice After the first hybrid ALLROUNDERs were purchased and subsequently the first successful turnkey project with an ALLROUNDER 520 H, the cooperation continued with the clean room project. For the automated production of the dental components – three different items in multiple moulds – the hybrid ALLROUNDER HIDRIVE series was also the obvious choice, as it combines the speed of the servo-electric toggle with a dynamic, hydraulic injection unit for maximum precision and performance. As Sandra Ender-Lercher says: “The catalogue of requirements for these plastic dental parts calls for precision so that there are no problems for the end customer with regard to quality or sterile packaging, for example.” Due to this machine characteristic, larger multicavity moulds can also be used in combination with smaller machine sizes. Ultimately, this is also a question of costs. Series production started in the first half of 2022. Two clean rooms work in combination to produce the dental technology components. The machine, which is docked directly to the Class 8 clean room, is equipped with a KUKA sixaxis robot equipped with the SELOGICA user interface on its control system. This robot removes the moulded parts which are transported to the second clean room via a conveyor belt. Two clean-air modules with main and pre-filters are fitted above the ALLROUNDER clamping unit and the robotic system housing. Lercher builds its own moulds. Robot systems with removal hands and grippers were independently commissioned directly on site. All machines are equipped with a host computer connection via OPC-UA as well as reject switches to ensure accurate tracking and quality of the manufactured parts. More than just a partnership “We have been exchanging information with ARBURG on clean room technology since 2019. And since we have now also successfully introduced the medical standard after IATF 16949, there was nothing standing in the way of the clean room facility,” comments Sandra Ender-Lercher. ARBURG’s pre-sales and after-sales service is particularly impressive. As Sandra Ender-Lercher says: “We are taken seriously as a customer. The right contact persons are always there for us, and so we always get to a practical solution quickly.” ARBURG GmbH + Co KG D 72290 Loßburg The ALLROUNDER is docked to a clean room in which moulded parts are tested and assembled. (Photo: PATRICK SAELY PHOTOGRAPHY) Two clean rooms are combined in the turnkey system, and parts handling is performed by a six-axis robot integrated into the machine controller. (Photo: PATRICK SAELY PHOTOGRAPHY)

www.reinraum.de<br />

NEWSLETTER<br />

www.cleanroom-online.com Edition <strong>EN</strong> <strong>12</strong>-<strong>2022</strong> | Page 20/42<br />

Cellefill, a new integrated<br />

solution to fast-track cell,<br />

gene and biological therapies<br />

Aseptic fill/finish experts Flexicon Liquid Filling, part of Watson-Marlow<br />

Fluid Technology Solutions (WMFTS), and barrier technology specialists<br />

Franz Ziel GmbH, today announce the launch of Cellefill- a<br />

turnkey, vial fill/finish system with an integrated barrier solution.<br />

Enhancing good manufacturing practice (GMP), customer compliance<br />

and efficient aseptic manufacturing is essential as new advanced<br />

therapy medicinal products (ATMPs), including cell, gene and biological<br />

products advance through clinical trials to commercialisation.<br />

To meet these new requirements, Cellefill integrates the features<br />

of Flexicon’s FPC60 aseptic vial filling machine with barrier technologies<br />

from Franz Ziel. Cellefill’s process design includes use of asepticsu<br />

single-use-systems (SUS) and pre-sterilised ready to use (RTU)<br />

product containers that enter the Grade A filling zone by a No Touch<br />

Transfer (NTT) debagging system. Cellefill is a GMP compliant solution<br />

that delivers enhanced levels of process flexibility to accelerate production<br />

of ATMPs and biological therapies.<br />

The emerging role of personalised medicine in ATMPs and biological<br />

therapies has led to a shift in how manufacturers approach batch<br />

production methods. Biopharmaceutical companies are increasingly<br />

looking for ways to manufacture the smaller batches needed for patient-specific<br />

medicines, in a way that is cost-effective to produce and<br />

validate.<br />

Meeting these customer needs, Cellefill maximises production<br />

efficiency with features including recipe driven, remote set-up, zero<br />

waste start-up and no format parts for the entire vial range.<br />

Steve Adams, Product Manager for Cellefill at WMFTS, says:<br />

“Through process flexibility, Cellefill enables the scale out and process<br />

repeatability our customers need to assure product quality at all levels<br />

of manufacturing. Providing expert guidance and support through a<br />

single point of contact, we are a committed project partner to biopharmaceutical<br />

companies at the cutting-edge of personalised medicine.<br />

„The challenge for the industry is to produce these new therapies<br />

quickly, safely and cost efficiently, with a system that can be rapidly<br />

changed over between batch or different small batch medicines.”<br />

Designed to suit various filling requirements and class cleanrooms,<br />

the Cellefill solution is available in three models with different<br />

barrier technologies. Each model delivers enhanced levels of process<br />

and quality assurance with highly accurate peristaltic pump performance,<br />

integrated barrier and environmental monitoring.<br />

Cellefill builds on the partners’ experience in providing technology<br />

and extensive support through validation, qualification and operator<br />

training to facilitate a smooth transition into GMP compliant and<br />

cost-effective manufacturing.<br />

Markus Horsch, division manager sales and marketing from Franz<br />

Ziel says: “Cellefill is a fully integrated vial fill/finish and barrier technology<br />

solution supporting enhanced levels of product quality and<br />

sterility assurance to mitigate risks of contamination. Cellefill adopts<br />

pre-designed and configurable modules to reduce project time and<br />

fast track therapies to market.<br />

„Cellefill minimises batch changeover time with enhanced cleanability,<br />

rapid Vapour-phase Hydrogen Peroxide (VHP) cycle times and<br />

gloveless operation in the aseptic core, while retaining the possibility<br />

of risk-based compliant interventions if needed in rare incidences to<br />

prevent batch loss.”<br />

The Cellefill solution enables a streamlined project timeline with<br />

integrated technical and GMP documentation to increase efficiency<br />

of the project validation and qualification stages.<br />

The modularity, flexibility, scale out capabilities and efficiencies<br />

establish Cellefill as a next generation vial fill/finish solution for new<br />

ATMP and biologic products as they advance through clinical trials to<br />

commercialisation.<br />

Watson-Marlow GmbH<br />

D 41569 Rommerskirchen

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!